miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling

Archive ouverte

El Helou, Rita | Pinna, Guillaume | Cabaud, Olivier | Wicinski, Julien | Bhajun, Ricky | Guyon, Laurent | Rioualen, Claire | Finetti, Pascal | Gros, Abigaelle | Mari, Bernard | Barbry, Pascal | Bertucci, François | Bidaut, Ghislain | Harel-Bellan, Annick | Birnbaum, Daniel | Charafe-Jauffret, Emmanuelle | Ginestier, Christophe

Edité par CCSD ; Elsevier Inc -

International audience. Breast cancer stem cells (bCSCs) have been implicated in tumor progression and therapeutic resistance; however, the molecular mechanisms that define this state are unclear. We have performed two microRNA (miRNA) gain- and loss-of-function screens to identify miRNAs that regulate the choice between bCSC self-renewal and differentiation. We find that micro-RNA (miR)-600 silencing results in bCSC expansion, while its overexpression reduces bCSC self-renewal, leading to decreased in vivo tumorigenicity. miR-600 targets stearoyl desaturase 1 (SCD1), an enzyme required to produce active, lipid-modified WNT proteins. In the absence of miR-600, WNT signaling is active and promotes self-renewal, whereas overexpression of miR-600 inhibits the production of active WNT and promotes bCSC differentiation. In a series of 120 breast tumors, we found that a low level of miR-600 is correlated with active WNT signaling and a poor prognosis. These findings highlight a miR-600-centered signaling network that governs bCSC-fate decisions and influences tumor progression

Suggestions

Du même auteur

Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome

Archive ouverte | El Helou, Rita | CCSD

International audience. Self-renewal and differentiation are two epigenetic programs that regulate stem cells fate. Dysregulation of these two programs leads to the development of cancer stem cells (CSCs). Recent ev...

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells

Archive ouverte | Arfaoui, Abir | CCSD

International audience. Therapeutic resistance is a major clinical challenge in oncology. Evidence identifies cancer stem cells (CSCs) as a driver of tumor evolution. Accordingly, the key stemness property unique to...

ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program

Archive ouverte | Charafe-Jauffret, Emmanuelle | CCSD

International audience. Cancer stem-like cells (CSC) have been widely studied, but their clinical relevance has yet to be established in breast cancer. Here, we report the establishment of primary breast tumor-deriv...

Chargement des enrichissements...